Postdoc in the Blelloch lab at UCSF, cancer immunologist and pharmacologist, Umich PIBS-Pharmacology PhD, PKU medicine graduate, and a proud dog/plant/fish mom.
UM Pharmacology is hiring! We're looking for a tenure-track faculty with interest in substance use disorders and expertise in behavioral pharmacology and/or biopsychology. For more info and to apply:
https://t.co/TR44sDFbcv
Here’s a timeline of my career
Orange=grants submitted
Green=grants funded
Lessons learned?
-persistence pays
-scientist=professional writer
-grant writing makes the science better
-scientist=entrepreneur. Not every “invention” is a hit (learned this from @ABCSharkTank)
From the May issue—
PVRL2 Suppresses Antitumor Immunity through PVRIG- and TIGIT-independent Pathways, by @JiulingYang4 t al.
https://t.co/3VmygkIOn0
@UCSFUrology
The SangokoyaLab@UCSF is recruiting postdoc(s) see https://t.co/rlJFF4Hvra for info. if attending ASIP Liver #slam24 or #ISSCR2024#stemcell conf --would love to share our work. looking forward to fantastic candidates🎉this lab♥️'s 🔥sensors, #RNA#iron#spatialbiology -pls RT!🙏🏾
the https://t.co/dBDF4xwEVu at UCSF is hiring! Looking for talented + intellectually curious post-docs + techs to build our team. We value an interest/background in RNA/molecular or stem cell biology, and welcome experience from other fields incl chemical biology +bioengineering
Wednesday, April 10th @UCSF at #AACR morning posters include 3D and Tissue Recombinant Models of Cancer (@MatthewStachler lab); Immune Cells in the Tumor Microenvironment (@lawfong lab) & more. Full poster list: https://t.co/gsYHmyogkS
It was truly an honor to present at the AACR Annual Meeting yesterday. Very grateful to #AACR24 organizers, my mentor @RobertBlelloch, and our incredible collaborators. Our new publication is now online in @CIR_AACR! For more details on the rising star immune checkpoint, PVRL2,⬇️
I’m excited to share that I will be giving a talk at the #AACR24 Annual Meeting on Monday, April 8th, from 4:05 to 4:20 PM. Please join me to hear more about how a new promising immune checkpoint target, PVRL2, may help cure cancer. https://t.co/ErvloOVOwY @AACR@UCSFCancer